THE ELSAH PROJECT PUSHES THE LIMITS OF WEARABLES

    NEXT STORY
    Panag Pharma Completes Phase 3 Trial With Awaye™
    PREV STORY
    Change in Orion Corporation’s holding of treasury shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TiGenix to present at the Crohn’s and Colitis Foundation’s Novel Technologies in Inflammatory Bowel Disease workshop in New York

    PRESS RELEASE TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in ...

    author_avatar
    NASDAQ Market News

    Precision Therapeutics Increases Equity Stake in Helomics to 25%

    MINNEAPOLIS, March 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Reports Second Quarter 2017 Financial Results

    - Clinical Pipeline Expands to Include TransCon PTH while Phase 3 Program for TransCon ...

    author_avatar
    NASDAQ Market News